Design, synthesis and biological evaluation studies of novel quinazoline derivatives as cytotoxic agents

Drug Research

Volumn 63, Issue 4, 2013, Pages 210-215

  Zayed, M F ^a,b   Hassan, M H ^a,b  

^a TAIBAH UNIVERSITY   (Saudi Arabia)

^b Al Azhar University   (Egypt)

Author keywords

anti cancer; anti inflammatory; diiodoanthranilic acid; leukemia

Indexed keywords

2(6,8 DIIODO 2 PHENYLQUINAZOLIN 4 YLAMINO) 3 METHYLBUTANOIC ACID; 2(6,8 DIIODO 2 PHENYLQUINAZOLIN 4 YLAMINO) 3 PHENYLPROPANOIC ACID; 2(6,8 DIIODO 2 PHENYLQUINAZOLIN 4 YLAMINO) 3(1H IMIDAZOL 4 YL) PROPANOIC ACID; 2(6,8 DIIODO 2 PHENYLQUINAZOLIN 4 YLAMINO) 3(1H INDOL 3 YL) PROPANOIC ACID; 2(6,8 DIIODO 2 PHENYLQUINAZOLIN 4 YLAMINO) 4 METHYLPENTANOIC ACID; 2(6,8 DIIODO 2 PHENYLQUINAZOLIN 4 YLAMINO) ACETIC ACID; 2(6,8 DIIODO 2 PHENYLQUINAZOLIN 4 YLAMINO) HEXANOIC ACID; 2(6,8 DIIODO 2 PHENYLQUINAZOLIN 4 YLAMINO) PROPANOIC ACID; ANTILEUKEMIC AGENT; CYTOTOXIC AGENT; ETOPOSIDE; QUINAZOLINE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DRUG DESIGN; DRUG SCREENING; DRUG STRUCTURE; DRUG SYNTHESIS; IC 50; LYMPHOMA CELL; NONHUMAN; PAW EDEMA; PHYSICAL CHEMISTRY; RAT;

EID: 84877777629     PISSN: 21949379     EISSN: 21949387     Source Type: Journal    
DOI: 10.1055/s-0033-1337929     Document Type: Article

References (23)

1. Abbas E. S., Awadallah M. F., Ibrahim A. N. et al. New quinazolinone-pyrimidine hybrids:Synthesis, anti-inflammatory, and ulcerogenicity studies. Eur J Med Chem: 2012; 53 141 149
2. Ali M. M., Mohamed A. Y., El-Bayouki M. A. et al. Synthesis of some new 4(3H)-quinazolinone-2-carboxaldehyde thiosemicarbazones and their metal complexes and a study on their anticonvulsant, analgesic, cytotoxic and antimicrobial activities. Eur J med Chem: 2010; 45 3365 3373
3. Marcelli C., Chappard D., Rossi J. F. et al. Histologic evidence of an abnormal bone remodeling in b-cell malignancies other than multiple myeloma. Cancer: 1988; 62 1163 1170
4. Balbaa M., Abdel-Megeed M., Diab T. et al. Inhibition of mammalian aspartate transcarbamylase by quinazolinone derivatives. J. Enzyme Inhib Med Chem: 2008; 23 483 492
5. Wakeling A. E., Guy S. P., Woodburn J. R. et al. An Orally Active Inhibitor of Epidermal Growth Factor Signaling with Potential for Cancer Therapy. Cancer Res: 2002; 62 5749 5754 (Pubitemid 35204731)
6. Rashood S. T., Aboldahab I. A., Nagi M. N. et al. Synthesis, Dihydrofolate Reductase Inhibition, and Molecular Modeling Study of Some New 4(3H)-Quinazolinone Analogues. Bioorg Med Chem: 2006; 14 8608 8621 (Pubitemid 44667527)
7. Hennequin L. F., Allen J., Breed J. et al. N-(5-chloro-1,3-benzodioxol-4- yl)-7-[2-(4-methylpiperazin-1-yl)ethoxy]-5- (tetrahydro-2H-pyran-4-yloxy) quinazoline 4-amine, a novel, highly selective, orally available, dual-specific c-Src/Abl kinase inhibitor. J Med Chem: 2006; 49 6465 6488 (Pubitemid 44657442)
8. Rocco S. A., Barbarini J. E., Rittner R. Efficient Synthesis of 4-Aminoquinazoline and Thieno[3,2-d]pyrimidin-4-ylamine Derivatives by Microwave Irradiation. Synthesis: 2004; 3 429 435
9. Mehta R. G., Moon R. C. Characterization of effective chemopreventive agents in mammary gland in vitro using an initiation-promotion protocol. Anti-cancer Res: 1991; 11 593 596
10. Harris R. E., Alshafie G. A., Abou-Issa H. et al. Chemoprevention of Breast Cancer in Rats by Celecoxib, a Cyclooxygenase 2 Inhibitor1. Cancer Res: 2001; 60 2101 2103
11. Daoyan W., Liwei W., Yanjuan H. et al. Celecoxib inhibits vascular endothelial growth factor expression in and reduces angiogenesis and metastasis of human pancreatic cancer via suppression of sp1 transcription factor activity. Cancer Res: 2004; 64 1916 1930
12. Yoshimura F., Rivkin A., gabarda A. E. et al. Synthesis and Conformational Analysis of (E)-9,10-Dehydroepothilone B, the Most Potent Epothilone Reported to Date: A Suggestive Linkage Between Observations in the Chemistry and Biology of Epothilones. Angew Chem Int Ed. 2003; 42 2518 2521
13. Srivastava S. K., Jha A., Agarwal S. K. et al. Synthesis and structure-activity relationships of potent antitumor active quinoline and naphthyridine derivatives. Anti-cancer Agents Med. Chem: 2007; 7 685 709 (Pubitemid 350237773)
14. Millon R. P. Impact of genetic diagnostics on drug development strategy. Nat. Rev: 2006; 5 459 462
15. Suh M. E., Kang M. J., Yoo H. W. et al. Synthesis and cytotoxicity of 2-methyl-1-substituted-imidazo [4,5-g]quinoline-4,9-dione and 7,8-dihydro-10H-1,4]oxazino[3',4':2,3]imidazo[4,5-g]quinoline-5,12-dio ne derivatives. Bioorg Med Chem: 2000; 8 2079 2083
16. Chandrika P. M., Yakaiah T., Rao A. R. et al. Synthesis of novel 4, 6-disubstituted quinazoline derivatives, their anti-inflammatory and anti-cancer activity (cytotoxic) against U937 leukemia cell lines. Eur J Med Chem: 2008; 43 846 852 (Pubitemid 351447327)
17. Yanming W., Chester A. M., Guo-Feng H. et al. Effects of lipophilicity on the affinity and nonspecific binding of iodinated benzothiazole derivatives. J mol neurosci: 2003; 20 255 260
18. Laznicek M., Beno P., Waisser K. et al. Quantitative chemical structure-pharmacokinetic data relationships. IV. Relationships between pharmacokinetic data and lipophilicity of iodine-substituted aromatic and arylaliphatic compounds. Cesko-Slovenska Farmacie: 1985; 34 353 358 (Pubitemid 16173950)
19. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods: 1983; 65 55 63 (Pubitemid 14203433)
20. Winter C. A., Risley E. A., Nuss G. W. Anti-inflammatory and antipyretic activities of indomethacin, 1-(p-chlorobenzoyl)-5-methoxy-2-methylindole-3- acetic acid. J Pharmacol Exp Ther: 1963; 141 369 376
21. Diwan P. V., Karwande I., Margaret I. et al. Pharmacology and biochemical evaluation of Tridax Procumbens on infl ammation. Indian J Pharmacol: 1989; 21 101 105
22. Smith J., Jones M. J., Houghton L. Future of health insurance. N Engl J Med: 1999; 965 325 329
23. Gasteiger J., Marsili M. Iterative partial equalization of orbital electronegativity - A rapid access to atomic charges. Tetrahedron: 1980; 36 3219 3228